Using negative pressure therapy to prevent complications after complex breast cancer surgery
Official title: Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery: a Prospective Randomized Controlled Trial
Run by Institut du Cancer de Montpellier - Val d'Aurelle · NCT06265558 · Data updated 2026-11-12
This study is testing if negative pressure therapy can help women recover better and avoid complications after complex breast cancer surgeries.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 254 (estimated) |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 7 sites (Dijon, Côte d'Or and 6 other locations) |
| Status | Recruiting |
| Started | April 15, 2025 |
| Main results expected | May 2027 |
| Study ends | July 2027 |
| Registry record updated | February 5, 2026 |
| Trial ID | NCT06265558 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 and older with unilateral invasive or in situ breast carcinoma who are undergoing complex breast surgery and have at least one risk factor for scarring disorders.
✕Probably not a fit
Patients who do not have any of the specified risk factors for scarring disorders or those with legal incapacity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of negative pressure therapy (NPT) in reducing postoperative complications following complex breast cancer surgeries, such as mastectomy with immediate breast reconstruction. The study aims to address the high rates of surgical wound complications, which can significantly impact patient recovery and quality of life. By enrolling female patients with specific risk factors for scarring disorders, the trial will assess the outcomes of NPT compared to standard care. The methodology includes monitoring complication rates and patient satisfaction post-surgery.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative complications and improve recovery for breast cancer patients undergoing complex surgeries.
How similar studies have gone: While there have been a few retrospective studies on negative pressure therapy in breast surgery, this trial aims to provide more robust evidence through a prospective approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Female ≥ 18 years 2. Patient with unilateral invasive or in situ breast carcinoma 3. Patient with or without neoadjuvant treatment 4. Patient presenting an indication for complex breast surgery by mastectomy with immediate breast reconstruction by implant or oncoplasty by T-shaped mammoplasty. 5. Patient presenting at least one of the following risk factors for scarring disorders: * Obesity with Body Mass Index BMI ≥ 30 and/or Cup size ≥ E * Active smoking or smoking cessation for less than one month * Diabetes * History of homolateral breast radiotherapy * Long-term corticosteroid therapy 6. Patient to have signed informed consent prior to study entry 7. Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests and other study procedures. 8. Patient affiliated with a health insurance plan. Exclusion Criteria: 1. Legal incapacity or limited legal capacity. Medical or psychological conditions preventing the patient from completing the study or signing the consent form. 2. Pregnant or breast-feeding patient as determined in medical records as part of standard patients care and follow-up 3. Patient under guardianship or safeguard of justice 4. Patient participating in an interventional study with the objective of wound healing 5. Any concurrent or planned surgical procedure on the contralateral breast
Where it's running
-
Centre Hospitalier de Nîmes
Nîmes, Gard, France Recruiting -
Centre Hospitalier de Montpellier
Montpellier, Hérault, France Recruiting -
Institut régional du Cancer de Montpellier
Montpellier, Hérault, France Recruiting -
Institut de Cancérologie de l'Ouest
Angers, Maine Et Loire, France Recruiting -
Centre Georges-François Leclerc
Dijon, Côte d'Or, France Not yet recruiting -
Institut Bergonié
Bordeaux, Gironde, France Not yet recruiting
Show 1 more location
-
Centre Léon Bérard
Lyon, Rhône, France Not yet recruiting
Study contacts
- Study coordinator: Mathias NERON, MD
- Email: mathias.neron@icm.unicancer.fr
- Phone: 467614813
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.